Corrigendum to the Notice of Postal Ballot issued on April 16, 2026, for the appointment of Ms. Gowree Gokhale (DIN: 09351661) as an Independent Director.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novartis India has issued a corrigendum to its April 16, 2026 postal ballot notice regarding the appointment of Ms. Gowree Gokhale as a Non-Executive Independent Director. The company discovered an inadvertent error where the resolution type was incorrectly stated as an 'Ordinary Resolution' when it should have been stated as a 'Special Resolution'. Ms. Gokhale was appointed as Additional Director (Independent) effective April 1, 2026, for a 5-year term ending March 31, 2031. The appointment fills a vacancy created when Ms. Sandra Martyres' term as Independent Director ended on April 18, 2026. The e-voting period runs from April 17, 2026 to May 16, 2026. This corrigendum is purely administrative and does not change any other terms of the appointment.
The correction from Ordinary to Special Resolution is a technical change requiring a higher threshold of shareholder approval (75% vs simple majority). This strengthens governance controls but does not affect the appointment itself or signal any concerns about the director nominee.